Taylor Asset Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-996,800
Closed -$3.81M 34
2016
Q3
$3.81M Hold
996,800
1.12% 18
2016
Q2
$5.21M Sell
996,800
-196,900
-16% -$1.12M 1.49% 15
2016
Q1
$5.74M Buy
1,193,700
+557,000
+87% +$2.45M 1.49% 16
2015
Q4
$2.99M Buy
636,700
+109,800
+21% +$475K 0.72% 20
2015
Q3
$1.95M Buy
526,900
+104,600
+25% +$727K 0.41% 24
2015
Q2
$3.61M Sell
422,300
-151,200
-26% -$1.51M 0.66% 19
2015
Q1
$5.19M Buy
573,500
+58,100
+11% +$730K 0.83% 25
2014
Q4
$7.44M Buy
+515,400
New +$7.48M 0.98% 29

Other funds holding CPHR

Taylor Asset Management's CPHR Position: Q4 2016 in Review

Taylor Asset Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 996,800 shares — an estimated $3.81M sold.

Taylor Asset Management first reported a position in CPHR in Q4 2014 and held it in 8 quarters. The position peaked at $7.44M in Q4 2014. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

  • Taylor Asset Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
  • Taylor Asset Management sold 996,800 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $3.81M.
  • Taylor Asset Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 8 quarters.
  • Taylor Asset Management's Cipher Pharmaceuticals Inc. position peaked at $7.44M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Taylor Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.